

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.05433670 |
| 2 | negative regulation of cell killing (GO:0031342) | 7.05433670 |
| 3 | protein K48-linked deubiquitination (GO:0071108) | 7.00378120 |
| 4 | Peyers patch development (GO:0048541) | 6.58114109 |
| 5 | mucosal-associated lymphoid tissue development (GO:0048537) | 6.58114109 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.47970240 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.47970240 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 6.47970240 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 6.47970240 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 6.47970240 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.47970240 |
| 12 | positive regulation of developmental pigmentation (GO:0048087) | 5.58907511 |
| 13 | detection of other organism (GO:0098543) | 5.54489412 |
| 14 | protein K63-linked deubiquitination (GO:0070536) | 5.53440931 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 5.46093545 |
| 16 | protein K11-linked deubiquitination (GO:0035871) | 5.43956083 |
| 17 | detection of bacterium (GO:0016045) | 5.29351950 |
| 18 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.08742877 |
| 19 | detection of molecule of bacterial origin (GO:0032490) | 4.94734583 |
| 20 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.93512271 |
| 21 | peptidyl-lysine dimethylation (GO:0018027) | 4.92946757 |
| 22 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.92359981 |
| 23 | detection of external biotic stimulus (GO:0098581) | 4.89460356 |
| 24 | endosome to melanosome transport (GO:0035646) | 4.81030312 |
| 25 | endosome to pigment granule transport (GO:0043485) | 4.81030312 |
| 26 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.76218128 |
| 27 | T-helper 1 type immune response (GO:0042088) | 4.67018769 |
| 28 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.62732694 |
| 29 | neutrophil activation (GO:0042119) | 4.61930051 |
| 30 | interleukin-1-mediated signaling pathway (GO:0070498) | 4.61636602 |
| 31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.61129841 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 4.60811635 |
| 33 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.59368390 |
| 34 | negative regulation of interleukin-17 production (GO:0032700) | 4.55460191 |
| 35 | cellular extravasation (GO:0045123) | 4.54570321 |
| 36 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.49983648 |
| 37 | respiratory burst (GO:0045730) | 4.47240224 |
| 38 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.47072844 |
| 39 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 4.44409238 |
| 40 | negative regulation of T-helper cell differentiation (GO:0045623) | 4.44409238 |
| 41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.41973912 |
| 42 | response to host immune response (GO:0052572) | 4.41973912 |
| 43 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.40836123 |
| 44 | lymph node development (GO:0048535) | 4.28134346 |
| 45 | microglial cell activation (GO:0001774) | 4.23877340 |
| 46 | detection of biotic stimulus (GO:0009595) | 4.23778626 |
| 47 | secondary metabolite biosynthetic process (GO:0044550) | 4.16152574 |
| 48 | negative regulation of leukocyte mediated immunity (GO:0002704) | 4.13725397 |
| 49 | granulocyte activation (GO:0036230) | 4.11498683 |
| 50 | mature B cell differentiation involved in immune response (GO:0002313) | 4.08748088 |
| 51 | response to host (GO:0075136) | 4.06386230 |
| 52 | response to host defenses (GO:0052200) | 4.06386230 |
| 53 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.06386230 |
| 54 | neutrophil mediated immunity (GO:0002446) | 4.01801638 |
| 55 | type I interferon signaling pathway (GO:0060337) | 3.94441151 |
| 56 | cellular response to type I interferon (GO:0071357) | 3.94441151 |
| 57 | response to type I interferon (GO:0034340) | 3.91238481 |
| 58 | immunoglobulin mediated immune response (GO:0016064) | 3.91191145 |
| 59 | * response to interleukin-15 (GO:0070672) | 3.88517069 |
| 60 | growth hormone receptor signaling pathway (GO:0060396) | 3.88167324 |
| 61 | macrophage activation (GO:0042116) | 3.87110013 |
| 62 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.85091852 |
| 63 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.81201142 |
| 64 | myeloid cell activation involved in immune response (GO:0002275) | 3.81007366 |
| 65 | regulation of memory T cell differentiation (GO:0043380) | 3.73867333 |
| 66 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.72568958 |
| 67 | negative regulation of T cell mediated immunity (GO:0002710) | 3.72406274 |
| 68 | regulation of mast cell degranulation (GO:0043304) | 3.70870194 |
| 69 | positive regulation of T cell cytokine production (GO:0002726) | 3.70578731 |
| 70 | negative regulation of phagocytosis (GO:0050765) | 3.64764444 |
| 71 | regulation of regulatory T cell differentiation (GO:0045589) | 3.63934139 |
| 72 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.59872158 |
| 73 | response to interferon-beta (GO:0035456) | 3.59809724 |
| 74 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.58276849 |
| 75 | adaptation of signaling pathway (GO:0023058) | 3.57472390 |
| 76 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.55293020 |
| 77 | head development (GO:0060322) | 3.51066085 |
| 78 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.48658117 |
| 79 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.48658117 |
| 80 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.48353587 |
| 81 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.48291478 |
| 82 | NIK/NF-kappaB signaling (GO:0038061) | 3.47318840 |
| 83 | cellular response to prostaglandin stimulus (GO:0071379) | 3.46642451 |
| 84 | myeloid leukocyte mediated immunity (GO:0002444) | 3.44180008 |
| 85 | regulation of T cell tolerance induction (GO:0002664) | 3.43471248 |
| 86 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.42043391 |
| 87 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.41243281 |
| 88 | B cell receptor signaling pathway (GO:0050853) | 3.39630817 |
| 89 | mature B cell differentiation (GO:0002335) | 3.38506127 |
| 90 | leukocyte degranulation (GO:0043299) | 3.36461669 |
| 91 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.35353550 |
| 92 | negative regulation of protein autophosphorylation (GO:0031953) | 3.35320993 |
| 93 | tricarboxylic acid metabolic process (GO:0072350) | 3.34443925 |
| 94 | viral transcription (GO:0019083) | 3.34267942 |
| 95 | positive regulation of mast cell activation (GO:0033005) | 3.34247875 |
| 96 | peptide biosynthetic process (GO:0043043) | 3.33577840 |
| 97 | germinal center formation (GO:0002467) | 3.29363704 |
| 98 | regulation of tolerance induction (GO:0002643) | 3.29305028 |
| 99 | regulation of interleukin-13 production (GO:0032656) | 3.27933475 |
| 100 | diterpenoid biosynthetic process (GO:0016102) | 3.27849979 |
| 101 | ribosomal small subunit assembly (GO:0000028) | 3.27618398 |
| 102 | regulation of leukocyte degranulation (GO:0043300) | 3.27603298 |
| 103 | cellular response to growth hormone stimulus (GO:0071378) | 3.22237984 |
| 104 | regulation of mast cell activation (GO:0033003) | 3.22025272 |
| 105 | regulation of developmental pigmentation (GO:0048070) | 3.21802261 |
| 106 | response to interferon-alpha (GO:0035455) | 3.21792067 |
| 107 | negative regulation of type 2 immune response (GO:0002829) | 3.20929235 |
| 108 | * cellular response to interleukin-15 (GO:0071350) | 3.18117656 |
| 109 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.15917577 |
| 110 | negative regulation of type I interferon production (GO:0032480) | 3.15546720 |
| 111 | macrophage differentiation (GO:0030225) | 3.15277880 |
| 112 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.15083519 |
| 113 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.15083519 |
| 114 | B cell mediated immunity (GO:0019724) | 3.12728247 |
| 115 | amyloid precursor protein catabolic process (GO:0042987) | 3.12495557 |
| 116 | translational termination (GO:0006415) | 3.12242191 |
| 117 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.09976295 |
| 118 | ear development (GO:0043583) | 3.09933917 |
| 119 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.06572509 |
| 120 | negative regulation of innate immune response (GO:0045824) | 3.04990911 |
| 121 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.02023790 |
| 122 | response to muramyl dipeptide (GO:0032495) | 3.01778238 |
| 123 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.01715287 |
| 124 | positive regulation of interferon-alpha production (GO:0032727) | 3.01552741 |
| 125 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.99588220 |
| 126 | negative regulation of interleukin-6 production (GO:0032715) | 2.99453188 |
| 127 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.99397894 |
| 128 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.97541462 |
| 129 | regulation of regulated secretory pathway (GO:1903305) | 2.97212199 |
| 130 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.93135050 |
| 131 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.92412727 |
| 132 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.91705404 |
| 133 | venous blood vessel morphogenesis (GO:0048845) | 2.91280532 |
| 134 | neutrophil chemotaxis (GO:0030593) | 2.90846639 |
| 135 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.90648455 |
| 136 | myeloid leukocyte activation (GO:0002274) | 2.90117691 |
| 137 | positive regulation of B cell differentiation (GO:0045579) | 2.90095501 |
| 138 | regulation of superoxide anion generation (GO:0032928) | 2.89476327 |
| 139 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.88741829 |
| 140 | leukocyte aggregation (GO:0070486) | 2.85587826 |
| 141 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.84663780 |
| 142 | negative regulation of interleukin-12 production (GO:0032695) | 2.84649838 |
| 143 | response to peptidoglycan (GO:0032494) | 2.83724640 |
| 144 | macrophage activation involved in immune response (GO:0002281) | 2.83675451 |
| 145 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.83402826 |
| 146 | T cell homeostasis (GO:0043029) | 2.82972514 |
| 147 | positive regulation of type 2 immune response (GO:0002830) | 2.82071952 |
| 148 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.81636515 |
| 149 | sulfation (GO:0051923) | 2.80453585 |
| 150 | platelet dense granule organization (GO:0060155) | 2.80259246 |
| 151 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.80099789 |
| 152 | regulation of immunoglobulin secretion (GO:0051023) | 2.78774254 |
| 153 | defense response to protozoan (GO:0042832) | 2.76613806 |
| 154 | pentose-phosphate shunt (GO:0006098) | 2.75674374 |
| 155 | pericardium development (GO:0060039) | 2.74621231 |
| 156 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.73780956 |
| 157 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.71353399 |
| 158 | post-embryonic morphogenesis (GO:0009886) | 2.70137429 |
| 159 | regulation of B cell differentiation (GO:0045577) | 2.65872497 |
| 160 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.61510858 |
| 161 | positive regulation of interleukin-4 production (GO:0032753) | 2.61371982 |
| 162 | positive regulation of tolerance induction (GO:0002645) | 2.59159598 |
| 163 | translational elongation (GO:0006414) | 2.57169754 |
| 164 | response to protozoan (GO:0001562) | 2.56497155 |
| 165 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.54501337 |
| 166 | lateral ventricle development (GO:0021670) | 2.54168522 |
| 167 | positive regulation of isotype switching (GO:0045830) | 2.53419393 |
| 168 | protein autoprocessing (GO:0016540) | 2.51576228 |
| 169 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.51169332 |
| 170 | secretory granule organization (GO:0033363) | 2.49293573 |
| 171 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.48993080 |
| 172 | gland morphogenesis (GO:0022612) | 2.48735186 |
| 173 | plasma membrane fusion (GO:0045026) | 2.48405463 |
| 174 | regulation of interleukin-17 production (GO:0032660) | 2.47539392 |
| 175 | regulation of chemokine biosynthetic process (GO:0045073) | 2.47398990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 6.40444585 |
| 2 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 5.23322154 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.90625501 |
| 4 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.01558051 |
| 5 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.94153885 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.85016455 |
| 7 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.77723963 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.72021090 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.47194946 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.45534022 |
| 11 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.44007387 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.41514485 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.39249566 |
| 14 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.35825640 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.31092021 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26118398 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.17059913 |
| 18 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.07342146 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.06473517 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.05609512 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.02367507 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.01133897 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.00306864 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.99686345 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97565263 |
| 26 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.94972409 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.92387065 |
| 28 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.89912257 |
| 29 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.88506605 |
| 30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.83949469 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.80531556 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.78744137 |
| 33 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.78206720 |
| 34 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.77919928 |
| 35 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.76185581 |
| 36 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.75018678 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 1.74970003 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.72302994 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.69028559 |
| 40 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.68847548 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68322407 |
| 42 | GATA1_19941826_ChIP-Seq_K562_Human | 1.67793869 |
| 43 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.65197645 |
| 44 | UTX_26944678_Chip-Seq_JUKART_Human | 1.64616315 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.64405317 |
| 46 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.63787308 |
| 47 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61721380 |
| 48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52256807 |
| 49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.52135832 |
| 50 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.50924344 |
| 51 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.46392511 |
| 52 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.44490829 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.44018784 |
| 54 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43094038 |
| 55 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.42768414 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.41132679 |
| 57 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.40177543 |
| 58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.40115081 |
| 59 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.39698584 |
| 60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.38872562 |
| 61 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38771421 |
| 62 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.35565155 |
| 63 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34812371 |
| 64 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34358045 |
| 65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.33833392 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31231011 |
| 67 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.30036962 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28974518 |
| 69 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28562925 |
| 70 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.28454519 |
| 71 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.25309597 |
| 72 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23895249 |
| 73 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23478034 |
| 74 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.23355975 |
| 75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22217615 |
| 76 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20361035 |
| 77 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.20193166 |
| 78 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19699400 |
| 79 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18950555 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18588649 |
| 81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18057156 |
| 82 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.16669925 |
| 83 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16409950 |
| 84 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15943802 |
| 85 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.15924212 |
| 86 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15330713 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14059673 |
| 88 | SPI1_23127762_ChIP-Seq_K562_Human | 1.13939007 |
| 89 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.13913151 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13752122 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.13727700 |
| 92 | MAF_26560356_Chip-Seq_TH2_Human | 1.13151121 |
| 93 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13131190 |
| 94 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09000207 |
| 95 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08891362 |
| 96 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07184166 |
| 97 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07046452 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06424680 |
| 99 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.05272764 |
| 100 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05041894 |
| 101 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04282120 |
| 102 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03113585 |
| 103 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01377846 |
| 104 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01278712 |
| 105 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00901744 |
| 106 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00658726 |
| 107 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98714329 |
| 108 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97834390 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97261749 |
| 110 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97033310 |
| 111 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96856834 |
| 112 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.96357249 |
| 113 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95235539 |
| 114 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95075853 |
| 115 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93399222 |
| 116 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.92296308 |
| 117 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90357025 |
| 118 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.89018674 |
| 119 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.86455744 |
| 120 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84921203 |
| 121 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.84813220 |
| 122 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83864925 |
| 123 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.80160653 |
| 124 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.77518099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003172_abnormal_lysosome_physiology | 3.92824945 |
| 2 | MP0004510_myositis | 3.87641810 |
| 3 | MP0003011_delayed_dark_adaptation | 3.81690902 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.15523967 |
| 5 | MP0002396_abnormal_hematopoietic_system | 2.84943741 |
| 6 | MP0009785_altered_susceptibility_to | 2.76391874 |
| 7 | MP0003436_decreased_susceptibility_to | 2.70167842 |
| 8 | MP0003303_peritoneal_inflammation | 2.65700248 |
| 9 | MP0005464_abnormal_platelet_physiology | 2.63792501 |
| 10 | MP0006082_CNS_inflammation | 2.59366549 |
| 11 | MP0005075_abnormal_melanosome_morpholog | 2.54535683 |
| 12 | MP0000015_abnormal_ear_pigmentation | 2.48566189 |
| 13 | MP0000685_abnormal_immune_system | 2.46903064 |
| 14 | MP0006054_spinal_hemorrhage | 2.46096374 |
| 15 | MP0002132_abnormal_respiratory_system | 2.30167023 |
| 16 | MP0002089_abnormal_postnatal_growth/wei | 2.22503625 |
| 17 | MP0002234_abnormal_pharynx_morphology | 2.19896169 |
| 18 | MP0008260_abnormal_autophagy | 2.15914097 |
| 19 | MP0002277_abnormal_respiratory_mucosa | 2.13250493 |
| 20 | MP0010329_abnormal_lipoprotein_level | 2.10707880 |
| 21 | MP0004130_abnormal_muscle_cell | 2.07028217 |
| 22 | MP0002419_abnormal_innate_immunity | 2.07002528 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.05284241 |
| 24 | MP0010234_abnormal_vibrissa_follicle | 1.99339989 |
| 25 | MP0003300_gastrointestinal_ulcer | 1.96490650 |
| 26 | MP0000465_gastrointestinal_hemorrhage | 1.91916056 |
| 27 | MP0005025_abnormal_response_to | 1.87648187 |
| 28 | MP0003075_altered_response_to | 1.83000741 |
| 29 | MP0005671_abnormal_response_to | 1.82588701 |
| 30 | MP0003828_pulmonary_edema | 1.77555009 |
| 31 | MP0002723_abnormal_immune_serum | 1.72411952 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.72175150 |
| 33 | MP0004808_abnormal_hematopoietic_stem | 1.70095019 |
| 34 | MP0003183_abnormal_peptide_metabolism | 1.68424239 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.66026509 |
| 36 | MP0003724_increased_susceptibility_to | 1.65008161 |
| 37 | MP0002139_abnormal_hepatobiliary_system | 1.64833278 |
| 38 | MP0001819_abnormal_immune_cell | 1.64681060 |
| 39 | MP0001800_abnormal_humoral_immune | 1.62031569 |
| 40 | MP0008961_abnormal_basal_metabolism | 1.60124295 |
| 41 | MP0004381_abnormal_hair_follicle | 1.58727676 |
| 42 | MP0005085_abnormal_gallbladder_physiolo | 1.53602153 |
| 43 | MP0003868_abnormal_feces_composition | 1.50652070 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.50568188 |
| 45 | MP0005451_abnormal_body_composition | 1.50114931 |
| 46 | MP0004883_abnormal_blood_vessel | 1.49845809 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.45994333 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.45994333 |
| 49 | MP0005174_abnormal_tail_pigmentation | 1.38571175 |
| 50 | MP0002398_abnormal_bone_marrow | 1.36817511 |
| 51 | MP0004859_abnormal_synaptic_plasticity | 1.36602864 |
| 52 | MP0000343_altered_response_to | 1.35875460 |
| 53 | MP0002148_abnormal_hypersensitivity_rea | 1.34026771 |
| 54 | MP0009840_abnormal_foam_cell | 1.32190792 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.32131515 |
| 56 | MP0008469_abnormal_protein_level | 1.31862560 |
| 57 | MP0000716_abnormal_immune_system | 1.30489133 |
| 58 | MP0002095_abnormal_skin_pigmentation | 1.29670255 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 1.26702375 |
| 60 | MP0002405_respiratory_system_inflammati | 1.25263787 |
| 61 | MP0005310_abnormal_salivary_gland | 1.24539881 |
| 62 | MP0002722_abnormal_immune_system | 1.23517245 |
| 63 | MP0000689_abnormal_spleen_morphology | 1.23326602 |
| 64 | MP0001853_heart_inflammation | 1.23106396 |
| 65 | MP0003448_altered_tumor_morphology | 1.21246222 |
| 66 | MP0005666_abnormal_adipose_tissue | 1.20911031 |
| 67 | MP0001790_abnormal_immune_system | 1.20051400 |
| 68 | MP0005387_immune_system_phenotype | 1.20051400 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.19933032 |
| 70 | MP0005164_abnormal_response_to | 1.19260755 |
| 71 | MP0005365_abnormal_bile_salt | 1.15084331 |
| 72 | MP0009278_abnormal_bone_marrow | 1.11224726 |
| 73 | MP0008875_abnormal_xenobiotic_pharmacok | 1.10744383 |
| 74 | MP0003690_abnormal_glial_cell | 1.10573449 |
| 75 | MP0005166_decreased_susceptibility_to | 1.10349251 |
| 76 | MP0002998_abnormal_bone_remodeling | 1.08147610 |
| 77 | MP0002429_abnormal_blood_cell | 1.07911504 |
| 78 | MP0004947_skin_inflammation | 1.07186866 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 1.05018836 |
| 80 | MP0002928_abnormal_bile_duct | 1.03210485 |
| 81 | MP0001533_abnormal_skeleton_physiology | 1.02951269 |
| 82 | MP0010155_abnormal_intestine_physiology | 1.02895841 |
| 83 | MP0003866_abnormal_defecation | 1.02277106 |
| 84 | MP0000751_myopathy | 1.00760073 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 0.99782857 |
| 86 | MP0001851_eye_inflammation | 0.94831383 |
| 87 | MP0005390_skeleton_phenotype | 0.94114184 |
| 88 | MP0005360_urolithiasis | 0.93047869 |
| 89 | MP0000371_diluted_coat_color | 0.92767864 |
| 90 | MP0001958_emphysema | 0.92482374 |
| 91 | MP0000516_abnormal_urinary_system | 0.90747200 |
| 92 | MP0005367_renal/urinary_system_phenotyp | 0.90747200 |
| 93 | MP0003045_fibrosis | 0.88755624 |
| 94 | MP0002118_abnormal_lipid_homeostasis | 0.87834383 |
| 95 | MP0009764_decreased_sensitivity_to | 0.87262977 |
| 96 | MP0008004_abnormal_stomach_pH | 0.86476597 |
| 97 | MP0000490_abnormal_crypts_of | 0.85990524 |
| 98 | MP0003638_abnormal_response/metabolism_ | 0.84427509 |
| 99 | MP0000703_abnormal_thymus_morphology | 0.83310217 |
| 100 | MP0009763_increased_sensitivity_to | 0.82901816 |
| 101 | MP0004858_abnormal_nervous_system | 0.82593690 |
| 102 | MP0001666_abnormal_nutrient_absorption | 0.82314843 |
| 103 | MP0005377_hearing/vestibular/ear_phenot | 0.82125814 |
| 104 | MP0003878_abnormal_ear_physiology | 0.82125814 |
| 105 | MP0000858_altered_metastatic_potential | 0.81973542 |
| 106 | MP0001663_abnormal_digestive_system | 0.81890553 |
| 107 | MP0000598_abnormal_liver_morphology | 0.81533143 |
| 108 | MP0000249_abnormal_blood_vessel | 0.80761780 |
| 109 | MP0002166_altered_tumor_susceptibility | 0.80377656 |
| 110 | MP0005595_abnormal_vascular_smooth | 0.79642879 |
| 111 | MP0003566_abnormal_cell_adhesion | 0.76578676 |
| 112 | MP0001986_abnormal_taste_sensitivity | 0.74992730 |
| 113 | MP0008874_decreased_physiological_sensi | 0.74818003 |
| 114 | MP0003806_abnormal_nucleotide_metabolis | 0.74610626 |
| 115 | MP0004147_increased_porphyrin_level | 0.74589780 |
| 116 | MP0000604_amyloidosis | 0.74560960 |
| 117 | MP0000767_abnormal_smooth_muscle | 0.72734922 |
| 118 | MP0005023_abnormal_wound_healing | 0.72441406 |
| 119 | MP0001873_stomach_inflammation | 0.70102094 |
| 120 | MP0002909_abnormal_adrenal_gland | 0.68821612 |
| 121 | MP0009379_abnormal_foot_pigmentation | 0.68802666 |
| 122 | MP0005375_adipose_tissue_phenotype | 0.68459679 |
| 123 | MP0003763_abnormal_thymus_physiology | 0.68362835 |
| 124 | MP0003221_abnormal_cardiomyocyte_apopto | 0.67283513 |
| 125 | MP0003091_abnormal_cell_migration | 0.67200318 |
| 126 | MP0005535_abnormal_body_temperature | 0.66866160 |
| 127 | MP0005248_abnormal_Harderian_gland | 0.65919418 |
| 128 | MP0005083_abnormal_biliary_tract | 0.64854926 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.64665598 |
| 130 | MP0003795_abnormal_bone_structure | 0.62481444 |
| 131 | MP0005319_abnormal_enzyme/_coenzyme | 0.57976994 |
| 132 | MP0002133_abnormal_respiratory_system | 0.57562799 |
| 133 | MP0005388_respiratory_system_phenotype | 0.57562799 |
| 134 | MP0002933_joint_inflammation | 0.57331615 |
| 135 | MP0002653_abnormal_ependyma_morphology | 0.53094197 |
| 136 | MP0002332_abnormal_exercise_endurance | 0.50062343 |
| 137 | MP0003252_abnormal_bile_duct | 0.48580338 |
| 138 | MP0002693_abnormal_pancreas_physiology | 0.46204547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 5.21931958 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 5.12172734 |
| 3 | Spontaneous hematomas (HP:0007420) | 5.11664301 |
| 4 | Hematochezia (HP:0002573) | 4.72514413 |
| 5 | Gastrointestinal infarctions (HP:0005244) | 4.71723109 |
| 6 | Myositis (HP:0100614) | 4.69428017 |
| 7 | Abnormality of the nasal mucosa (HP:0000433) | 4.43554252 |
| 8 | Chronic obstructive pulmonary disease (HP:0006510) | 4.41407859 |
| 9 | Obstructive lung disease (HP:0006536) | 4.41407859 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.26604714 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 4.25220259 |
| 12 | Orchitis (HP:0100796) | 4.20281213 |
| 13 | Reduced antithrombin III activity (HP:0001976) | 4.19995753 |
| 14 | Hypochromic anemia (HP:0001931) | 4.08207308 |
| 15 | Polycythemia (HP:0001901) | 4.00520806 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 3.94377558 |
| 17 | Optic neuritis (HP:0100653) | 3.94377558 |
| 18 | Amyloidosis (HP:0011034) | 3.94352645 |
| 19 | Increased IgE level (HP:0003212) | 3.90407130 |
| 20 | Cerebral hemorrhage (HP:0001342) | 3.82087817 |
| 21 | Thrombocytosis (HP:0001894) | 3.75672032 |
| 22 | Urticaria (HP:0001025) | 3.75355273 |
| 23 | Agammaglobulinemia (HP:0004432) | 3.64222556 |
| 24 | Epistaxis (HP:0000421) | 3.63117814 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.53926580 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.53926580 |
| 27 | Colitis (HP:0002583) | 3.53091285 |
| 28 | Hemoptysis (HP:0002105) | 3.52769766 |
| 29 | Arterial thrombosis (HP:0004420) | 3.48805491 |
| 30 | Menorrhagia (HP:0000132) | 3.48592500 |
| 31 | Panhypogammaglobulinemia (HP:0003139) | 3.47456035 |
| 32 | Albinism (HP:0001022) | 3.46639829 |
| 33 | Episodic fever (HP:0001954) | 3.40887641 |
| 34 | Prolonged bleeding time (HP:0003010) | 3.39749672 |
| 35 | Pulmonary embolism (HP:0002204) | 3.31574685 |
| 36 | Conjunctival telangiectasia (HP:0000524) | 3.26281981 |
| 37 | Thrombophlebitis (HP:0004418) | 3.25568306 |
| 38 | Abnormal platelet function (HP:0011869) | 3.25126067 |
| 39 | Impaired platelet aggregation (HP:0003540) | 3.25126067 |
| 40 | Hemorrhage of the eye (HP:0011885) | 3.19373962 |
| 41 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.18253310 |
| 42 | Portal hypertension (HP:0001409) | 3.16000755 |
| 43 | Encephalitis (HP:0002383) | 3.13644128 |
| 44 | Anorexia (HP:0002039) | 3.08190194 |
| 45 | Recurrent skin infections (HP:0001581) | 2.94747418 |
| 46 | T lymphocytopenia (HP:0005403) | 2.94176578 |
| 47 | Spontaneous abortion (HP:0005268) | 2.90181227 |
| 48 | Chest pain (HP:0100749) | 2.89390807 |
| 49 | Recurrent viral infections (HP:0004429) | 2.89014552 |
| 50 | Abnormality of T cell number (HP:0011839) | 2.85569137 |
| 51 | Abnormality of the hepatic vasculature (HP:0006707) | 2.84118605 |
| 52 | Leukocytosis (HP:0001974) | 2.83052737 |
| 53 | Esophageal varix (HP:0002040) | 2.79256949 |
| 54 | Joint swelling (HP:0001386) | 2.77069983 |
| 55 | Meningitis (HP:0001287) | 2.76089560 |
| 56 | Recurrent fungal infections (HP:0002841) | 2.74659615 |
| 57 | Inflammation of the large intestine (HP:0002037) | 2.70391625 |
| 58 | Chronic hepatic failure (HP:0100626) | 2.67111873 |
| 59 | Recurrent abscess formation (HP:0002722) | 2.66980986 |
| 60 | Gingival bleeding (HP:0000225) | 2.66646103 |
| 61 | Increased IgM level (HP:0003496) | 2.66445495 |
| 62 | Chronic otitis media (HP:0000389) | 2.62268287 |
| 63 | Osteomyelitis (HP:0002754) | 2.62190751 |
| 64 | Interstitial pulmonary disease (HP:0006530) | 2.62123473 |
| 65 | Abnormality of T cells (HP:0002843) | 2.59110373 |
| 66 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.58716130 |
| 67 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.58075135 |
| 68 | Cellulitis (HP:0100658) | 2.57965981 |
| 69 | Keratoconjunctivitis sicca (HP:0001097) | 2.53431035 |
| 70 | Sepsis (HP:0100806) | 2.52294648 |
| 71 | Abnormality of secondary sexual hair (HP:0009888) | 2.52282934 |
| 72 | Abnormality of the axillary hair (HP:0100134) | 2.52282934 |
| 73 | Acute hepatic failure (HP:0006554) | 2.52223264 |
| 74 | Pustule (HP:0200039) | 2.51295404 |
| 75 | Gastrointestinal inflammation (HP:0004386) | 2.50534378 |
| 76 | Abnormality of the peritoneum (HP:0002585) | 2.50310493 |
| 77 | Abnormality of the pleura (HP:0002103) | 2.49974246 |
| 78 | Granulocytopenia (HP:0001913) | 2.48796611 |
| 79 | Glucose intolerance (HP:0000833) | 2.44292840 |
| 80 | Visceral angiomatosis (HP:0100761) | 2.43333457 |
| 81 | Abnormality of the intrinsic pathway (HP:0010989) | 2.41135768 |
| 82 | Gangrene (HP:0100758) | 2.40324490 |
| 83 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.39395274 |
| 84 | Joint hemorrhage (HP:0005261) | 2.38414583 |
| 85 | Recurrent bacterial skin infections (HP:0005406) | 2.37862457 |
| 86 | Eczematoid dermatitis (HP:0000976) | 2.35338632 |
| 87 | Lymphopenia (HP:0001888) | 2.33269246 |
| 88 | Bile duct proliferation (HP:0001408) | 2.27885575 |
| 89 | Abnormal biliary tract physiology (HP:0012439) | 2.27885575 |
| 90 | Hemangiomatosis (HP:0007461) | 2.27568666 |
| 91 | Toxemia of pregnancy (HP:0100603) | 2.27180489 |
| 92 | Fatigue (HP:0012378) | 2.26427489 |
| 93 | Hypergammaglobulinemia (HP:0010702) | 2.26024848 |
| 94 | Abnormality of the endocardium (HP:0004306) | 2.25590244 |
| 95 | Ocular albinism (HP:0001107) | 2.24895858 |
| 96 | Abnormality of the pericardium (HP:0001697) | 2.24796041 |
| 97 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.21752346 |
| 98 | Keratoconjunctivitis (HP:0001096) | 2.21233175 |
| 99 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.20291003 |
| 100 | Glomerulopathy (HP:0100820) | 2.19736121 |
| 101 | Premature skin wrinkling (HP:0100678) | 2.19655053 |
| 102 | Pulmonary infiltrates (HP:0002113) | 2.19454289 |
| 103 | Viral hepatitis (HP:0006562) | 2.16676171 |
| 104 | Increased cerebral lipofuscin (HP:0011813) | 2.16500141 |
| 105 | Acne (HP:0001061) | 2.16283159 |
| 106 | Keratitis (HP:0000491) | 2.16233530 |
| 107 | Skin ulcer (HP:0200042) | 2.14027991 |
| 108 | Amaurosis fugax (HP:0100576) | 2.13321408 |
| 109 | Retinal atrophy (HP:0001105) | 2.13220481 |
| 110 | Metaphyseal cupping (HP:0003021) | 2.12565393 |
| 111 | Deep venous thrombosis (HP:0002625) | 2.10763919 |
| 112 | Premature loss of primary teeth (HP:0006323) | 2.10362669 |
| 113 | Generalized hypopigmentation (HP:0007513) | 2.10039338 |
| 114 | Myocardial infarction (HP:0001658) | 2.08269892 |
| 115 | Gingivitis (HP:0000230) | 2.05627032 |
| 116 | Abnormal platelet volume (HP:0011876) | 2.04739702 |
| 117 | Slow saccadic eye movements (HP:0000514) | 2.04656641 |
| 118 | Eosinophilia (HP:0001880) | 2.04170253 |
| 119 | Abnormality of T cell physiology (HP:0011840) | 2.03094938 |
| 120 | Hepatosplenomegaly (HP:0001433) | 2.02826897 |
| 121 | Type I transferrin isoform profile (HP:0003642) | 2.02734849 |
| 122 | Hypoproteinemia (HP:0003075) | 2.00283276 |
| 123 | Nasal polyposis (HP:0100582) | 2.00132264 |
| 124 | IgM deficiency (HP:0002850) | 1.98006976 |
| 125 | Purpura (HP:0000979) | 1.97451140 |
| 126 | Subacute progressive viral hepatitis (HP:0006572) | 1.96946984 |
| 127 | Constricted visual fields (HP:0001133) | 1.95971193 |
| 128 | Difficulty running (HP:0009046) | 1.95518050 |
| 129 | Ridged nail (HP:0001807) | 1.93818807 |
| 130 | Pulmonary fibrosis (HP:0002206) | 1.92323501 |
| 131 | Recurrent pneumonia (HP:0006532) | 1.92224857 |
| 132 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.91602260 |
| 133 | Hypermelanotic macule (HP:0001034) | 1.91464248 |
| 134 | Microcytic anemia (HP:0001935) | 1.91235604 |
| 135 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.90673572 |
| 136 | Cavernous hemangioma (HP:0001048) | 1.89869809 |
| 137 | Iris hypopigmentation (HP:0007730) | 1.89305211 |
| 138 | Migraine (HP:0002076) | 1.87502972 |
| 139 | Abnormality of macrophages (HP:0004311) | 1.86413083 |
| 140 | Peritonitis (HP:0002586) | 1.83765302 |
| 141 | Congenital, generalized hypertrichosis (HP:0004540) | 1.83289235 |
| 142 | Mitral stenosis (HP:0001718) | 1.82142596 |
| 143 | Abnormality of the common coagulation pathway (HP:0010990) | 1.81506270 |
| 144 | Abnormality of iron homeostasis (HP:0011031) | 1.81339321 |
| 145 | Recurrent bronchitis (HP:0002837) | 1.81003061 |
| 146 | Skin nodule (HP:0200036) | 1.80753354 |
| 147 | Skin rash (HP:0000988) | 1.79945330 |
| 148 | Cheilitis (HP:0100825) | 1.79798958 |
| 149 | Petechiae (HP:0000967) | 1.79737931 |
| 150 | Vertigo (HP:0002321) | 1.79095986 |
| 151 | Abnormal hemoglobin (HP:0011902) | 1.78363445 |
| 152 | Abnormal glucose tolerance (HP:0001952) | 1.75449498 |
| 153 | Vasculitis (HP:0002633) | 1.74321011 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 4.82560260 |
| 2 | PNCK | 4.66939834 |
| 3 | IRAK4 | 3.58476153 |
| 4 | TGFBR1 | 3.53104558 |
| 5 | MAP3K9 | 3.29888640 |
| 6 | MAP2K3 | 3.29845437 |
| 7 | CAMK1G | 2.95668231 |
| 8 | MAP3K13 | 2.85909454 |
| 9 | TNK2 | 2.68126784 |
| 10 | RIPK4 | 2.52970647 |
| 11 | KSR2 | 2.45544526 |
| 12 | MAP4K1 | 2.34415482 |
| 13 | BRSK2 | 2.31407247 |
| 14 | FLT3 | 2.30880513 |
| 15 | PKN2 | 2.11356708 |
| 16 | ZAP70 | 2.03771795 |
| 17 | ERN1 | 2.02578878 |
| 18 | ARAF | 1.98367276 |
| 19 | MAP3K3 | 1.97541115 |
| 20 | JAK3 | 1.92106096 |
| 21 | BLK | 1.88174600 |
| 22 | CSNK1A1L | 1.88091807 |
| 23 | MAP3K12 | 1.86781209 |
| 24 | CAMK1 | 1.77725699 |
| 25 | MAP2K6 | 1.75493366 |
| 26 | PRPF4B | 1.72194693 |
| 27 | PIK3CA | 1.66403126 |
| 28 | TXK | 1.64010471 |
| 29 | MOS | 1.60041379 |
| 30 | FGR | 1.51936782 |
| 31 | EPHB1 | 1.51642460 |
| 32 | SIK3 | 1.42878752 |
| 33 | YES1 | 1.41757939 |
| 34 | LRRK2 | 1.39610371 |
| 35 | PTK6 | 1.38480926 |
| 36 | EEF2K | 1.38427201 |
| 37 | WEE1 | 1.38064921 |
| 38 | IKBKE | 1.34519893 |
| 39 | JAK1 | 1.23797794 |
| 40 | BTK | 1.20205797 |
| 41 | KIT | 1.19213706 |
| 42 | MAP3K1 | 1.18594384 |
| 43 | MAPKAPK3 | 1.17833768 |
| 44 | PRKD2 | 1.11920965 |
| 45 | TYK2 | 1.10011464 |
| 46 | CSNK1G3 | 1.08863394 |
| 47 | MAP3K14 | 1.08811645 |
| 48 | MAP3K11 | 1.07856137 |
| 49 | CDK19 | 1.05265354 |
| 50 | MARK3 | 1.01752493 |
| 51 | FES | 1.01511282 |
| 52 | IRAK1 | 1.00476032 |
| 53 | MAP3K6 | 0.99341352 |
| 54 | SYK | 0.97986121 |
| 55 | RET | 0.95958530 |
| 56 | MUSK | 0.94337511 |
| 57 | BRSK1 | 0.94123236 |
| 58 | NME2 | 0.93761708 |
| 59 | SMG1 | 0.92390554 |
| 60 | ITK | 0.91458421 |
| 61 | CSF1R | 0.90067743 |
| 62 | HCK | 0.88232750 |
| 63 | RAF1 | 0.87680936 |
| 64 | IRAK2 | 0.86248207 |
| 65 | PDGFRB | 0.85685795 |
| 66 | SIK1 | 0.83995450 |
| 67 | TAOK2 | 0.80869027 |
| 68 | TESK2 | 0.80298729 |
| 69 | TAOK3 | 0.79829865 |
| 70 | STK10 | 0.77272549 |
| 71 | LCK | 0.77076621 |
| 72 | JAK2 | 0.74619349 |
| 73 | CSNK1G2 | 0.74608575 |
| 74 | TAOK1 | 0.73093210 |
| 75 | MAPK4 | 0.70877372 |
| 76 | CSNK1G1 | 0.70791419 |
| 77 | DYRK1B | 0.70246391 |
| 78 | PDK1 | 0.70087446 |
| 79 | EPHA3 | 0.70070669 |
| 80 | STK38 | 0.69596225 |
| 81 | TTN | 0.67915167 |
| 82 | ABL2 | 0.65412259 |
| 83 | ICK | 0.64622044 |
| 84 | TRIB3 | 0.62763885 |
| 85 | MAPK12 | 0.62471150 |
| 86 | MAP3K2 | 0.62338273 |
| 87 | TBK1 | 0.60047693 |
| 88 | MAP3K5 | 0.59833362 |
| 89 | SIK2 | 0.57400798 |
| 90 | FGFR3 | 0.57025836 |
| 91 | MARK2 | 0.56425408 |
| 92 | STK11 | 0.55919973 |
| 93 | BMPR2 | 0.55432040 |
| 94 | LYN | 0.54122048 |
| 95 | MAP2K4 | 0.53350251 |
| 96 | IKBKB | 0.53082474 |
| 97 | SGK3 | 0.52386343 |
| 98 | GRK6 | 0.52293935 |
| 99 | PRKCQ | 0.50760643 |
| 100 | PDPK1 | 0.49976826 |
| 101 | PRKG2 | 0.49786123 |
| 102 | HIPK2 | 0.49730344 |
| 103 | CSK | 0.48906180 |
| 104 | CDC42BPA | 0.48700463 |
| 105 | TIE1 | 0.48583449 |
| 106 | TEC | 0.48507897 |
| 107 | DAPK2 | 0.48313228 |
| 108 | RPS6KA4 | 0.48004476 |
| 109 | NLK | 0.47856692 |
| 110 | MST4 | 0.47585787 |
| 111 | NTRK1 | 0.47504442 |
| 112 | MAP3K7 | 0.46291979 |
| 113 | PIK3CG | 0.45330641 |
| 114 | PTK2 | 0.44348890 |
| 115 | FYN | 0.43139551 |
| 116 | EGFR | 0.43057635 |
| 117 | PRKCZ | 0.41997383 |
| 118 | ALK | 0.41033886 |
| 119 | KDR | 0.40765004 |
| 120 | MAPK7 | 0.39482352 |
| 121 | PIM1 | 0.38728419 |
| 122 | KSR1 | 0.38327142 |
| 123 | DYRK3 | 0.33517267 |
| 124 | CAMKK1 | 0.33406883 |
| 125 | MAP3K8 | 0.32010490 |
| 126 | RPS6KA6 | 0.31479635 |
| 127 | SGK2 | 0.31454246 |
| 128 | SRC | 0.30661558 |
| 129 | ERBB2 | 0.30153011 |
| 130 | FGFR4 | 0.29988447 |
| 131 | PRKCH | 0.29566073 |
| 132 | RPS6KA1 | 0.29366726 |
| 133 | MATK | 0.28825355 |
| 134 | MAPKAPK2 | 0.27784913 |
| 135 | PAK2 | 0.27609155 |
| 136 | RPS6KC1 | 0.26081989 |
| 137 | RPS6KL1 | 0.26081989 |
| 138 | CDK5 | 0.25504216 |
| 139 | PTK2B | 0.23080605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 6.91121950 |
| 2 | Sulfur relay system_Homo sapiens_hsa04122 | 3.15324335 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.49662642 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.29532982 |
| 5 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.23973249 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.19178186 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.06794686 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.71455765 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.69632027 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.63490359 |
| 11 | Platelet activation_Homo sapiens_hsa04611 | 1.63075319 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61445408 |
| 13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.57434304 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.54848225 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.54067306 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.52812017 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.50662566 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.50628092 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.49590574 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.42832148 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.40333393 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36714429 |
| 23 | Ribosome_Homo sapiens_hsa03010 | 1.34638456 |
| 24 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.26012834 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.19362814 |
| 26 | Hepatitis C_Homo sapiens_hsa05160 | 1.18502200 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.17179969 |
| 28 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.10230373 |
| 29 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.09307176 |
| 30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.07146873 |
| 31 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.06946349 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.06910992 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.06503272 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06157529 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.04568081 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.03821300 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.03787172 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02726295 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.00516740 |
| 40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97953653 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 0.97784926 |
| 42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.97246793 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 0.96973738 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.96069833 |
| 45 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.95806400 |
| 46 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.94869755 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93549628 |
| 48 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.93251421 |
| 49 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.89256635 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 0.89206029 |
| 51 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88733181 |
| 52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.88650505 |
| 53 | * Endocytosis_Homo sapiens_hsa04144 | 0.88573695 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.87209805 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.87077303 |
| 56 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86620564 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85766691 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85312520 |
| 59 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84423820 |
| 60 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.84010011 |
| 61 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83136293 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82605906 |
| 63 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.82230809 |
| 64 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.81847956 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79325188 |
| 66 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78977663 |
| 67 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78569549 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78058175 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77311297 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76336955 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.75938040 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75801959 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75664442 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.74231362 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.74191658 |
| 76 | Malaria_Homo sapiens_hsa05144 | 0.73705406 |
| 77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70340406 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.69545593 |
| 79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69256956 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68089760 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67997665 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66486399 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65611612 |
| 84 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65555067 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65516569 |
| 86 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65169256 |
| 87 | Measles_Homo sapiens_hsa05162 | 0.64690670 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.64144682 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63815556 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63187867 |
| 91 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.63177509 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62756205 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62258676 |
| 94 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62142962 |
| 95 | Bile secretion_Homo sapiens_hsa04976 | 0.61673722 |
| 96 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61158586 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.60848811 |
| 98 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60628224 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.60589996 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59541824 |
| 101 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.58857142 |
| 102 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58795545 |
| 103 | Lysosome_Homo sapiens_hsa04142 | 0.58221241 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.58060177 |
| 105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57980260 |
| 106 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.57653881 |
| 107 | Carbon metabolism_Homo sapiens_hsa01200 | 0.57410335 |
| 108 | Salmonella infection_Homo sapiens_hsa05132 | 0.57410247 |
| 109 | Asthma_Homo sapiens_hsa05310 | 0.57170406 |
| 110 | Glioma_Homo sapiens_hsa05214 | 0.55229872 |
| 111 | Apoptosis_Homo sapiens_hsa04210 | 0.55036999 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53704446 |
| 113 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53310780 |
| 114 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.53203514 |
| 115 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.52415920 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50725245 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50415594 |
| 118 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50009357 |
| 119 | Influenza A_Homo sapiens_hsa05164 | 0.49633332 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49565764 |
| 121 | Phagosome_Homo sapiens_hsa04145 | 0.49127542 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48690339 |
| 123 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48482631 |
| 124 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48471595 |
| 125 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47577291 |
| 126 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.47518132 |
| 127 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47508050 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47455075 |
| 129 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47089258 |
| 130 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.46294590 |
| 131 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46216846 |
| 132 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46031332 |
| 133 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42796952 |
| 134 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41712295 |
| 135 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41640539 |
| 136 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41370853 |
| 137 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.40777715 |
| 138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40086892 |
| 139 | Olfactory transduction_Homo sapiens_hsa04740 | 0.39759860 |
| 140 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.38616307 |
| 141 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38390812 |
| 142 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38088913 |

